about
AAV-Mediated Gene Supplementation Therapy in Achromatopsia Type 2: Preclinical Data on Therapeutic Time Window and Long-Term EffectsGene therapy for inherited retinal and optic nerve degenerations.Long-term retinal cone rescue using a capsid mutant AAV8 vector in a mouse model of CNGA3-achromatopsia.Retinal Cyclic Nucleotide-Gated Channels: From Pathophysiology to Therapy.
P2860
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Gene therapy for achromatopsia.
@en
Gene therapy for achromatopsia.
@nl
type
label
Gene therapy for achromatopsia.
@en
Gene therapy for achromatopsia.
@nl
prefLabel
Gene therapy for achromatopsia.
@en
Gene therapy for achromatopsia.
@nl
P2093
P2860
P356
P1476
Gene therapy for achromatopsia
@en
P2093
Christian Schön
Martin Biel
Stylianos Michalakis
P2860
P356
10.1002/JGM.2944
P577
2017-03-01T00:00:00Z